Global Healthcare Currency Hedged ETF

DRUG
Invest in a portfolio of the world's leading healthcare companies
Factsheet
Info pack
Loading
Info pack
close
Invest with us
Investment goal
Growth

Overview

Fund Objective

DRUG aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars.

Benefits

Healthcare – a global growth opportunity

Ageing populations, rising living standards and ongoing medical advancements are expected to support increasing ongoing demand for healthcare products and services.

Simple access to global healthcare giants

Access a diversified portfolio of the world’s leading healthcare companies, such as Johnson & Johnson, Pfizer and Roche, in one trade.

Cost-effective

Passive, index-tracking approach means no ‘active manager’ fees, making DRUG a cost-effective investment for those seeking exposure to the global healthcare sector.

There are risks associated with an investment in DRUG, including market risk, international investment risk, healthcare sector risk and concentration risk. Investment value can go up and down. An investment in the Fund should only be considered as a part of a broader portfolio, taking into account your particular circumstances, including your tolerance for risk. For more information on risks and other features of the Fund, please see the Product Disclosure Statement and Target Market Determination, both available on this website.

Invest in DRUG with Betashares Direct

Invest in DRUG brokerage-free with a Betashares Direct account. You can also buy or sell DRUG using an online broker or your financial adviser.

Key facts

Profile

Units outstanding* (#) 23,143,021
Management fee and cost** (p.a.) 0.57%
Distribution frequency Semi-annual
Distribution reinvestment plan (DRP) Full or partial participation available
Issuer Betashares Capital Ltd
Registry Link Market Services

* As at 19 December 2024
**Certain additional costs apply. Please refer to PDS.

Net assets*
$182,158,765

Pricing information

Current price
Last trade*
% Change (prev day)
Bid (delayed)
Offer (delayed)
NAV * As at 19 December 2024
NAV/Unit* $7.87
* Data is delayed by at least 20 minutes.
Download NAV history
keyboard_arrow_down

Past performance is not indicative of future performance. Please refer to "Fund returns after fees" for additional information regarding performance/return information.

Trading information

ASX code DRUG
Bloomberg code DRUG AU
IRESS code DRUG.AXW
iNAV IRESS code N/A
Market makers Susquehanna Pacific

Index information

Index Nasdaq Global ex-Australia Healthcare Hedged AUD Index
Index provider Nasdaq
Index ticker N/A
Bloomberg index ticker NQXAUHHN Index
Download index methodology
keyboard_arrow_down

Performance

Fund returns after fees (%)

 FundIndex
1 month-0.87%-0.83%
3 months-8.27%-8.16%
6 months0.41%0.68%
1 year12.13%12.63%
3 year p.a.4.70%5.14%
5 year p.a.7.41%7.87%
10 year p.a.-8.02%
Since inception8.12%8.48%
Inception date4-Aug-16-
* As at 29 November 2024.
Past performance is not an indicator of future performance. Returns are calculated in Australian dollars using net asset value per unit at the start and end of the specified period and do not reflect brokerage or the bid ask spread that investors incur when buying and selling units on the ASX. Returns are after fund management costs, assume reinvestment of any distributions and do not take into account tax paid as an investor in the Fund. Returns for periods longer than one year are annualised. Current performance may be higher or lower than the performance shown.

Holdings and allocation

Portfolio holdings

Name Weight (%)
UNITEDHEALTH GROUP INC 7.7
ELI LILLY & CO 7.4
NOVO NORDISK A/S 5.7
JOHNSON & JOHNSON 5.6
ABBVIE INC 4.9
MERCK & CO INC 4.0
ASTRAZENECA PLC 3.4
THERMO FISHER SCIENTIFIC INC 3.4
ABBOTT LABORATORIES 3.4
ROCHE HOLDING AG 3.3
Download CSV
keyboard_arrow_down
* As at 20 December 2024. Excludes cash

Sector allocation

Pharmaceuticals
43.6%
Health Care Equipment
16.7%
Biotechnology
13.7%
Managed Health Care
11.5%
Life Sciences Tools & Services
7.6%
Health Care Supplies
3.0%
Health Care Services
1.5%
Health Care Facilities
1.0%
Personal Care Products
0.6%
Other
0.9%

* As of 29 November 2024

Country allocation

United States
78.7%
Denmark
6.1%
Switzerland
4.7%
Japan
3.9%
Britain
3.4%
France
1.2%
Netherlands
0.8%
South Korea
0.3%
China
0.3%
Other
0.6%

* As of 29 November 2024

Distributions

Frequency and yield

Distribution frequency Semi-Annual
12 mth distribution yield* 3.0%

*As at 29 November 2024. Yield is calculated by summing the prior 12-month per unit distributions divided by the closing NAV per unit at the end of the relevant period. Yield will vary and may be lower at time of investment. Past performance is not indicative of future performance.

You can elect DRP by logging into Link’s Investor Centre. Once you are logged in, please proceed to the 'Payments and Tax' tab and select 'Reinvestment Plans'.

Recent distributions

Ex DateRecord DatePayment DateDistribution Unit ($)Annual Distribution Return (%) (1)
1-Jul-242-Jul-2416-Jul-24$0.2230163.24%
2-Jan-243-Jan-2417-Jan-24$0.0267120.35%
3-Jul-234-Jul-2318-Jul-23-0.34%
3-Jan-234-Jan-2318-Jan-23$0.0261980.33%
1-Jul-224-Jul-2218-Jul-22-0.24%
4-Jan-225-Jan-2219-Jan-22$0.0191885.70%
1-Jul-212-Jul-2116-Jul-21$0.3498415.55%
4-Jan-215-Jan-2119-Jan-21$0.0166021.00%
1-Jul-202-Jul-2016-Jul-20$0.0429231.13%
2-Jan-203-Jan-2017-Jan-20$0.0249430.46%
2-Jan-193-Jan-1917-Jan-19$0.0186944.03%
2-Jul-183-Jul-1817-Jul-18$0.1844493.77%
2-Jan-183-Jan-1817-Jan-18$0.016460.35%

1 This is the annual distribution return to the end of the relevant distribution date. The distribution return reflects the contribution to total investment return made by the Fund's distributions. Distribution return is calculated as the total return less the growth return. Total return is calculated as the percentage change in a continuing investor's interest in the Fund assuming reinvestment of all distributions back into the Fund (and no other application or withdrawal), net of ongoing fees. Growth return is the Fund's return excluding distributions, net of ongoing fees. Past performance is not indicative of future performance.

Announcements

ASX Announcements: DRUG

pdf
Showing page of